InvestSMART

Sigma Healthcare Limited (ASX: SIG) - Announcements

Current share price for SIG : $2.975 0.005 (0.17%)+

ASX company news and announcements for Sigma Healthcare Limited (SIG) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Sigma Healthcare Limited (SIG) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Sigma Healthcare Limited (SIG), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Sigma Healthcare Limited (SIG)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$34,458 Ceasing to be a substantial holder 13 Feb 2025 5:15PM $2.910 $2.985 risen by 2.58%
$34,458 Initial Director's Interest Notice 13 Feb 2025 11:39AM $2.855 $2.985 risen by 4.55%
$34,458 Initial Director's Interest Notice 13 Feb 2025 11:37AM $2.855 $2.985 risen by 4.55%
$34,458 Initial Director's Interest Notice 13 Feb 2025 11:36AM $2.855 $2.985 risen by 4.55%
$34,458 Initial Director's Interest Notice 13 Feb 2025 11:35AM $2.855 $2.985 risen by 4.55%
$34,458 Ceasing to be a substantial holder 13 Feb 2025 8:18AM $2.760 $2.985 risen by 8.15%
$34,458 Ceasing to be a Substantial Holder from HMC 12 Feb 2025 6:08PM $2.760 $2.985 risen by 8.15%
$34,458 Merger with Chemist Warehouse - Implementation of Scheme 12 Feb 2025 2:14PM $2.745 $2.985 risen by 8.74%
$34,458 Application for quotation of securities - SIG 12 Feb 2025 11:17AM $2.735 $2.985 risen by 9.14%
$34,458 Becoming a substantial holder 12 Feb 2025 8:22AM $2.790 $2.985 risen by 6.99%
$34,458 Change in substantial holding 11 Feb 2025 5:09PM $2.790 $2.985 risen by 6.99%
$34,458 Becoming a substantial holder 11 Feb 2025 2:58PM $2.800 $2.985 risen by 6.61%
$34,458 Sigma Healthcare - Final Prospectus 10 Feb 2025 7:59PM $2.830 $2.985 risen by 5.48%
$34,458 Proposed issue of securities - SIG 7 Feb 2025 2:11PM $2.960 $2.985 risen by 0.84%
$34,458 Sigma FY25 Trading Update 7 Feb 2025 10:29AM $2.830 $2.985 risen by 5.48%
$34,458 Change in substantial holding 6 Feb 2025 7:38PM $2.830 $2.985 risen by 5.48%
$34,458 Merger with Chemist Warehouse - Scheme effective 4 Feb 2025 12:30PM $2.835 $2.985 risen by 5.29%
$34,458 Merger with Chemist Warehouse - Court Approval of Scheme 3 Feb 2025 11:00AM $2.820 $2.985 risen by 5.85%
$34,458 Merger with Chemist Warehouse - Scheme Meeting Results 29 Jan 2025 8:05PM $3.030 $2.985 fallen by 1.49%
$34,458 Merger with Chemist Warehouse - General Meeting Results 29 Jan 2025 6:57PM $3.030 $2.985 fallen by 1.49%
$34,458 Chairman's Address & Presentation for General Meeting 29 Jan 2025 1:22PM $3.030 $2.985 fallen by 1.49%
$34,458 Trading Halt 29 Jan 2025 8:56AM $3.030 $2.985 fallen by 1.49%
$34,458 CW - Trading Update 1H FY25 Record Sales & Margin Expansion 28 Jan 2025 10:44AM $2.750 $2.985 risen by 8.55%
$34,458 Change in substantial holding 3 Jan 2025 7:00PM $2.780 $2.985 risen by 7.37%
$34,458 Industry funding agreement finalised with Government 19 Dec 2024 4:19PM $2.630 $2.985 risen by 13.50%

76 - 100 of 676 results

Page 4 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.